Patent · US Active

Bicyclic heterocycles as FGFR inhibitors

US9533984B2 · kind B2 · utility

38Cited by

26References

6Claims

0Family size

Assignee

Incyte Corporation · US

Inventors

Yaping Sun · Lexington, US
Liang Lu · Hockessin, US
Wenqing Yao · Kennett Square, US
Jincong Zhuo · Boothwyn, US
Liangxing Wu · Wilmington, US
Meizhong Xu · Hockessin, US
Ding-Quan Qian · Newark, US
Chunhong He · Boothwyn, US
Fenglei Zhang · Berwyn, US

Key dates

Filing date	Apr 18, 2014
Grant date	Jan 3, 2017
Priority date	—
Expiry date	Apr 18, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.